CN104547616A - 一种中药片剂及其制备方法 - Google Patents
一种中药片剂及其制备方法 Download PDFInfo
- Publication number
- CN104547616A CN104547616A CN201410856144.7A CN201410856144A CN104547616A CN 104547616 A CN104547616 A CN 104547616A CN 201410856144 A CN201410856144 A CN 201410856144A CN 104547616 A CN104547616 A CN 104547616A
- Authority
- CN
- China
- Prior art keywords
- tablet
- chinese medicine
- gelatinizing
- powder
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 239000000843 powder Substances 0.000 claims abstract description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 238000004108 freeze drying Methods 0.000 claims abstract description 14
- 239000002904 solvent Substances 0.000 claims abstract description 10
- 239000002245 particle Substances 0.000 claims abstract description 7
- 241000190633 Cordyceps Species 0.000 claims description 35
- 235000008216 herbs Nutrition 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- 241000222336 Ganoderma Species 0.000 claims description 4
- 235000000421 Lepidium meyenii Nutrition 0.000 claims description 4
- 240000000759 Lepidium meyenii Species 0.000 claims description 4
- 241000169546 Lycium ruthenicum Species 0.000 claims description 4
- 235000012902 lepidium meyenii Nutrition 0.000 claims description 4
- 239000012467 final product Substances 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 14
- 238000000227 grinding Methods 0.000 abstract description 10
- 238000001035 drying Methods 0.000 abstract description 5
- 238000002156 mixing Methods 0.000 abstract description 5
- 239000004480 active ingredient Substances 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 3
- 239000003826 tablet Substances 0.000 description 37
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 12
- 230000002085 persistent effect Effects 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 8
- 238000001514 detection method Methods 0.000 description 8
- 239000013543 active substance Substances 0.000 description 7
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 6
- 229960005305 adenosine Drugs 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 239000002671 adjuvant Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000001476 alcoholic effect Effects 0.000 description 4
- 238000005336 cracking Methods 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 238000007710 freezing Methods 0.000 description 4
- 230000008014 freezing Effects 0.000 description 4
- 238000010298 pulverizing process Methods 0.000 description 4
- 238000003556 assay Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 239000006189 buccal tablet Substances 0.000 description 2
- 229940046011 buccal tablet Drugs 0.000 description 2
- 238000011978 dissolution method Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000001117 sulphuric acid Substances 0.000 description 2
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 241000221751 Claviceps purpurea Species 0.000 description 1
- 241001076416 Dendrobium tosaense Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- ILRCGYURZSFMEG-UHFFFAOYSA-N Salidroside Natural products OC1C(O)C(O)C(CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000007891 compressed tablet Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000011858 nanopowder Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000007430 reference method Methods 0.000 description 1
- ILRCGYURZSFMEG-RQICVUQASA-N salidroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-RQICVUQASA-N 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
成分 | 规格 | 硬度(N) | 最短~最长崩解时间 | 成品率(%) | 脆碎度 |
实施例1 | Φ8mm,250mg | 72.8±2.3 | 8’57”~9’24” | 99.3% | 合格 |
实施例2 | Φ8mm,250mg | 47.6±1.4 | 7’35”~9’48” | 98.2% | 合格 |
实施例3 | Φ8mm,250mg | 85.6±2.9 | 6’16”~10’37” | 99.2% | 合格 |
实施例4 | Φ8mm,250mg | 53.9±1.9 | 8’44”-9’27” | 98.1% | 合格 |
对比例1 | Φ8mm,250mg | 8.3±5.9 | 42’22”-50’18” | 48.2% | 不合格 |
对比例2 | Φ8mm,250mg | 29.3±5.7 | >60’ | 80.1% | 合格 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410856144.7A CN104547616B (zh) | 2014-12-31 | 2014-12-31 | 一种中药片剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410856144.7A CN104547616B (zh) | 2014-12-31 | 2014-12-31 | 一种中药片剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104547616A true CN104547616A (zh) | 2015-04-29 |
CN104547616B CN104547616B (zh) | 2018-04-03 |
Family
ID=53065387
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410856144.7A Active CN104547616B (zh) | 2014-12-31 | 2014-12-31 | 一种中药片剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104547616B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105029440A (zh) * | 2015-08-04 | 2015-11-11 | 苏州泽达兴邦医药科技有限公司 | 一种玛咖保健食品及制作方法 |
CN105249472A (zh) * | 2015-11-06 | 2016-01-20 | 孟令刚 | 一种玛咖营养制品的制备方法 |
CN105661510A (zh) * | 2016-01-19 | 2016-06-15 | 陕西嘉禾生物科技股份有限公司 | 一种提高免疫力的玛咖复方片制备方法 |
CN108159191A (zh) * | 2018-03-06 | 2018-06-15 | 青海紫元生态科技开发有限公司 | 壮阳健肾的组合物、用途和口服液及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101342195A (zh) * | 2008-08-18 | 2009-01-14 | 张伟华 | 一种中药微粉物的制备方法 |
CN101584472A (zh) * | 2009-06-18 | 2009-11-25 | 中南大学 | 一种尾参片剂的生产工艺 |
CN103751561A (zh) * | 2014-02-18 | 2014-04-30 | 云南众爱生物科技有限公司 | 一种铁皮石斛纯粉片及制备方法 |
CN103766907A (zh) * | 2014-02-20 | 2014-05-07 | 云南众爱生物科技有限公司 | 一种纯玛咖片及其制备方法 |
CN103920012A (zh) * | 2014-04-01 | 2014-07-16 | 安徽源牌实业(集团)有限责任公司 | 石斛纯微粉含片及其制备方法 |
-
2014
- 2014-12-31 CN CN201410856144.7A patent/CN104547616B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101342195A (zh) * | 2008-08-18 | 2009-01-14 | 张伟华 | 一种中药微粉物的制备方法 |
CN101584472A (zh) * | 2009-06-18 | 2009-11-25 | 中南大学 | 一种尾参片剂的生产工艺 |
CN103751561A (zh) * | 2014-02-18 | 2014-04-30 | 云南众爱生物科技有限公司 | 一种铁皮石斛纯粉片及制备方法 |
CN103766907A (zh) * | 2014-02-20 | 2014-05-07 | 云南众爱生物科技有限公司 | 一种纯玛咖片及其制备方法 |
CN103920012A (zh) * | 2014-04-01 | 2014-07-16 | 安徽源牌实业(集团)有限责任公司 | 石斛纯微粉含片及其制备方法 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105029440A (zh) * | 2015-08-04 | 2015-11-11 | 苏州泽达兴邦医药科技有限公司 | 一种玛咖保健食品及制作方法 |
CN105249472A (zh) * | 2015-11-06 | 2016-01-20 | 孟令刚 | 一种玛咖营养制品的制备方法 |
CN105661510A (zh) * | 2016-01-19 | 2016-06-15 | 陕西嘉禾生物科技股份有限公司 | 一种提高免疫力的玛咖复方片制备方法 |
CN108159191A (zh) * | 2018-03-06 | 2018-06-15 | 青海紫元生态科技开发有限公司 | 壮阳健肾的组合物、用途和口服液及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104547616B (zh) | 2018-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102406679B (zh) | 一种中药西洋参口含片 | |
CN104435743A (zh) | 一种铁皮石斛超微粉的制备方法 | |
CN104547616A (zh) | 一种中药片剂及其制备方法 | |
CN102631377A (zh) | 冬虫夏草冻干纳米粉片及其制备方法 | |
CN104189502B (zh) | 一种铁皮石斛微粉片及其制备方法 | |
CN104224738A (zh) | 一种单味中药丸剂及其制备方法 | |
TWI549700B (zh) | 一種三七破壁製劑 | |
CN104721207B (zh) | 一种药物组合物 | |
CN103381193B (zh) | 一种红景天微粉片及其制备方法 | |
CN104055816A (zh) | 一种超微破壁三七组合物及其制备方法 | |
CN101019898A (zh) | 冬虫夏草的粉碎方法及制剂 | |
CN110575442A (zh) | 一种发酵冬虫夏草菌粉片剂 | |
CN107648280A (zh) | 发酵冬虫夏草菌粉片 | |
CN104800332B (zh) | 调经养颜片及其制备方法 | |
CN101708307A (zh) | 一种用于治疗乳腺增生的药物及其制法 | |
CN105030847A (zh) | 一种纳米中草药超细粉的制备方法 | |
CN1785265A (zh) | 一种乙肝扶正快速分散固体制剂及其制备方法 | |
CN102885780A (zh) | 一种提高白藜芦醇生物利用度的方法 | |
CN1785290A (zh) | 一种壮腰健肾快速分散固体制剂及其制备方法 | |
CN107496670A (zh) | 一种暗紫贝母超细粉体的制备方法 | |
CN104225046A (zh) | 一种抗骨增生片及其制备方法 | |
CN105616451A (zh) | 一种含有环糊精的虫草微粉及其制备方法和制剂 | |
CN104116795B (zh) | 一种具有抗皮肤癌活性的中药组合物及其用途 | |
CN103505477A (zh) | 鲜虫草超微钝粉片及其制备方法 | |
CN103211775B (zh) | 一种分散片 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Chinese medicinal tablet and preparation method thereof Effective date of registration: 20181221 Granted publication date: 20180403 Pledgee: Bank of Bohai, Limited by Share Ltd, Yichang branch|Bank of China, Limited by Share Ltd, Three Gorges Branch|Bank of Hubei Limited by Share Ltd Yichang Nanhu sub branch|Bank of Hankou, Limited by Share Ltd, Yichang branch Pledgor: Dongyangguang Pharmaceutical Co., Ltd., Guangdong Registration number: 2018420000072 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210603 Granted publication date: 20180403 Pledgee: Bank of Bohai Limited by Share Ltd. Yichang branch|Bank of China Limited by Share Ltd. Three Gorges Branch|Bank of Hubei Limited by Share Ltd. Yichang Nanhu sub branch|Bank of Hankou Limited by Share Ltd. Yichang branch Pledgor: SUNSHINE LAKE PHARMA Co.,Ltd. Registration number: 2018420000072 |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210615 Address after: 443300 baotawan village, Lucheng, Yidu City, Yichang City, Hubei Province Patentee after: YICHANG SHANCHENGSHUIDU CORDYCEPS Co.,Ltd. Address before: 523808 No. 1 Industrial North Road, Songshan Industrial Park, Songshan, Guangdong, Dongguan, Hubei Patentee before: SUNSHINE LAKE PHARMA Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: The invention relates to a traditional Chinese medicine tablet and a preparation method thereof Effective date of registration: 20210630 Granted publication date: 20180403 Pledgee: Bank of Bohai Limited by Share Ltd. Yichang branch|Bank of China Limited by Share Ltd. Three Gorges Branch|Bank of Hubei Limited by Share Ltd. Yichang Nanhu sub branch|Bank of Hankou Limited by Share Ltd. Yichang branch Pledgor: YICHANG SHANCHENGSHUIDU CORDYCEPS Co.,Ltd. Registration number: Y2021420000062 |